Intramuscular electroporation of a plasmid encoding human plasminogen kringle 5 induces growth inhibition of lewis lung carcinoma in mice

Cancer Biotherapy and Radiopharmaceuticals

Volumn 23, Issue 3, 2008, Pages 332-341

  Li, Yonghong ^a,b   Han, Wei ^a   Zhang, Yongchao ^b   Yuan, Liyong ^b   Shi, Xinchang ^b   Yu, Yongli ^c   Zhang, Yingqi ^a   Wang, Junzhi ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b NATIONAL INSTITUTE FOR THE CONTROL OF PHARMACEUTICAL AND BIOLOGICAL PRODUCTS   (China)

^c JILIN UNIVERSITY   (China)

Author keywords

Antiangiogenesis; Gene therapy; Intramuscular electroporation; Plasmid; Plasminogen kringle 5; Tumor

Indexed keywords

ANGIOGENESIS INHIBITOR; PLASMID DNA; PLASMINOGEN KRINGLE 5;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GENE THERAPY; CANCER INHIBITION; CELL MIGRATION; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG POTENCY; ELECTROPORATION; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; KRINGLE DOMAIN; LEWIS CARCINOMA; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; SINGLE DRUG DOSE; SURVIVAL TIME; TUMOR MODEL;

ANGIOGENESIS INHIBITORS; ANIMALS; CARCINOMA, LEWIS LUNG; ELECTROPORATION; ENDOTHELIAL CELLS; GENE THERAPY; HELA CELLS; HUMANS; MICE; MICE, INBRED C57BL; MUSCLES; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PEPTIDE FRAGMENTS; PLASMIDS; PLASMINOGEN; PROTEIN STRUCTURE, TERTIARY;

EID: 46449120870     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2007.0437     Document Type: Article

References (29)

1. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003;9:653.
2. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182.
3. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994;79:315.
4. Cao Y, Ji RW, Davidson D, et al. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells. J Biol Chem 1996;271:29461.
5. Cao Y, Chen A, An SS, et al. Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J Biol Chem 1997;272:22924.
6. Yang X, Cheng R, Li C, et al. Kringle 5 of human plasminogen suppresses hepatocellular carcinoma growth both in grafted and xenografted mice by anti-angiogenic activity. Cancer Biol Ther 2006;5:399.
7. Perri SR, Martineau D, Francois M, et al. Plasminogen Kringle 5 blocks tumor progression by antiangiogenic and proinflammatory pathways. Mol Cancer Ther 2007;6:441.
8. Lu H, Dhanabal M, Volk R, et al. Kringle 5 causes cell cycle arrest and apoptosis of endothelial cells. Biochem Biophys Res Commun 1999;258:668.
9. Nguyen TM, Subramanian IV, Kelekar A, et al. Kringle 5 of human plasminogen, an angiogenesis inhibitor, induces both autophagy and apoptotic death in endothelial cells. Blood 2007;109:4793.
10. Perri SR, Nalbantoglu J, Annabi B, et al. Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression. Cancer Res 2005;65:8359.
11. Mir LM, Bureau MF, Gehl J, et al. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci U S A 1999;96:4262.
12. Prudhomme GJ, Glinka Y, Khan AS, Draghia-Akli R. Electroporation-enhanced nonviral gene transfer for the prevention or treatment of immunological, endocrine and neoplastic diseases. Curr Gene Ther 2006;6:243.
13. Yu WZ, Li XX, She HC, et al. Gene transfer of kringle 5 of plasminogen by electroporation inhibits corneal neovascularization. Ophthalmic Res 2003;35:239.
14. Stemmer WPC, Crameri A, Ha KD, et al. Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides. Gene 1995;164:49.
15. Tarui T, Majumdar M, Miles LA, et al. Plamin induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin. J Biol Chem 2002;277:33564.
16. Sugawara Y, Gee SJ, Sanborn JR, et al. Development of a highly sensitive enzyme-linked immunosorbent assay based on polyclonal antibodies for the detection of polychlorinated dibenzo-p-dioxins. Anal Chem 1998;70:1092.
17. Folkman J. Antiangiogenic gene therapy. Proc Natl Acad Sci U S A 1998;95:9064.
18. Blezinger P, Wang J, Gondo M, et al. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene. Nat Biotechnol 1999;17:343.
19. Schofield JP, Caskey CT. Non-viral approaches to gene therapy. Br Med Bull 1995;51:56.
20. Wolff JA, Ludtke JJ, Acsadi G, et al. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet 1992;1:363.
21. Anderson GL, Evans GA. Introduction and expression of DNA molecules in eukaryotic cells by electroporation. Biotechniques 1988;6:650.
22. Heller R, Gilbert R, Jaroszeski M. Clinical applications of electrochemotherapy. Adv Drug Deliv Rev 1999;35:119.
23. Aihara H, Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998;16:867.
24. Hanna E, Zhang X, Woodlis J, et al. Intramuscular electroporation delivery of IL-12 gene for treatment of squamous cell carcinoma located at distant site. Cancer Gene Ther 2001;8:151.
25. Rizzuto G, Cappelletti M, Mennuni C, et al. Gene electrotransfer results in a high-level transduction of rat skeletal muscle and corrects anemia of renal failure. Hum Gene Ther 2000;11:1891.
26. Harrison RL, Byrne BJ, Tung L. Electroporation-mediated gene transfer in cardiac tissue. FEBS Lett 1998;435:1.
27. Wang XD, Tang JG, Xie XL, et al. A comprehensive study of optimal conditions for naked plasmid DNA transfer into skeletal muscle by electroporation. J Gene Med 2005;7:1235.
28. Schertzer JD, Plant DR, Lynch GS. Optimizing plasmid-based gene transfer for investigating skeletal muscle structure and function. Mol Ther 2006;13:795.
29. Satkauskas S, André F, Bureau MF, et al. Electrophoretic component of electric pulses determines the efficacy of in vivo DNA electrotransfer. Hum Gene Ther 2005;16:1194.